{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:47:48Z","timestamp":1787942868576,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.labinv.2022.100003","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T06:14:33Z","timestamp":1673936073000},"page":"100003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension"],"prefix":"10.1016","volume":"103","author":[{"given":"Tomohiro","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-8414","authenticated-orcid":false,"given":"Masahide","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.labinv.2022.100003_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib2","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.labinv.2022.100003_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.labinv.2022.100003_bib7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.labinv.2022.100003_bib8","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.2012.131","article-title":"Arterial stiffness and pulse pressure in CKD and ESRD","volume":"82","author":"Briet","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.labinv.2022.100003_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.07761109","article-title":"Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease","volume":"5","author":"Foley","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.labinv.2022.100003_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.labinv.2022.100003_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12413","article-title":"Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction","volume":"6","author":"Nolte","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.labinv.2022.100003_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.labinv.2022.100003_bib14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.labinv.2022.100003_bib15","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.labinv.2022.100003_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570161118666200420102100","article-title":"New insights into the role of FGF-23 and Klotho in cardiovascular disease in chronic kidney disease patients","volume":"19","author":"Memmos","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"issue":"9","key":"10.1016\/j.labinv.2022.100003_bib18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp Cell Res"},{"issue":"Pt A","key":"10.1016\/j.labinv.2022.100003_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsbmb.2013.12.009","article-title":"Regulation of the extrarenal CYP27B1-hydroxylase","volume":"144","author":"Adams","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.labinv.2022.100003_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-nutr-071812-161203","article-title":"Extrarenal vitamin D activation and interactions between vitamin D2, vitamin D3, and vitamin D analogs","volume":"33","author":"Jones","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.labinv.2022.100003_bib21","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1152\/ajpendo.00076.2014","article-title":"Active vitamin D deficiency mediated by extracellular calcium and phosphorus results in male infertility in young mice","volume":"308","author":"Sun","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.labinv.2022.100003_bib22","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.labinv.2022.100003_bib23","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.labinv.2022.100003_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fendo.2018.00278","article-title":"Paracrine effects of FGF23 on the heart","volume":"9","author":"Leifheit-Nestler","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.labinv.2022.100003_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","article-title":"Molecular mechanisms of vitamin D action","volume":"92","author":"Haussler","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"10.1016\/j.labinv.2022.100003_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneph.2013.74","article-title":"The effect of vitamin D status on risk factors for cardiovascular disease","volume":"9","author":"Gunta","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.labinv.2022.100003_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.labinv.2022.100003_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.labinv.2022.100003_bib31","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"43","key":"10.1016\/j.labinv.2022.100003_bib32","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.labinv.2022.100003_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1269\/jrr.10156","article-title":"Enhanced radiosensitivity in 1,25-dihydroxyvitamin D3 deficient mice","volume":"52","author":"Zhang","year":"2011","journal-title":"J\u00a0Radiat Res"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1232-6","article-title":"Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-\u03b2\/Smad2\/3-mediated epithelial-mesenchymal transition","volume":"20","author":"Li","year":"2019","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCULATIONAHA.109.883777","article-title":"Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction","volume":"121","author":"Silberman","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib36","first-page":"731","article-title":"Animal models for the study of arterial hypertension","volume":"36","author":"Dornas","year":"2011","journal-title":"J\u00a0Biosci"},{"issue":"8","key":"10.1016\/j.labinv.2022.100003_bib37","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ajpath.2020.04.006","article-title":"Mouse models of heart failure with preserved or reduced ejection fraction","volume":"190","author":"Noll","year":"2020","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCRESAHA.111.258251","article-title":"Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity","volume":"110","author":"Lovelock","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.labinv.2022.100003_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/en.2009-0806","article-title":"Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure","volume":"151","author":"Sam","year":"2010","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","article-title":"Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction","volume":"7","author":"Tanaka","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.labinv.2022.100003_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/HYPERTENSIONAHA.109.134932","article-title":"Effects of fixed-dose isosorbide dinitrate\/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure","volume":"54","author":"Wilson","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.labinv.2022.100003_bib42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/HYPERTENSIONAHA.110.165829","article-title":"Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice","volume":"57","author":"Grobe","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.labinv.2022.100003_bib43","doi-asserted-by":"crossref","first-page":"H1781","DOI":"10.1152\/ajpheart.00972.2010","article-title":"Mild DOCA-salt hypertension: sympathetic system and role of renal nerves","volume":"300","author":"Kandlikar","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1-3","key":"10.1016\/j.labinv.2022.100003_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2009.05.013","article-title":"The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats","volume":"616","author":"Henley","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.labinv.2022.100003_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000330188","article-title":"Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression","volume":"34","author":"Mizobuchi","year":"2011","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.labinv.2022.100003_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2017.10.006","article-title":"Echocardiographic evaluation of diastolic function in mouse models of heart disease","volume":"114","author":"Schnelle","year":"2018","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.labinv.2022.100003_bib48","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"issue":"7120","key":"10.1016\/j.labinv.2022.100003_bib49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.labinv.2022.100003_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/ijms23010166","article-title":"Fibroblast growth factor 23 stimulates cardiac fibroblast activity through phospholipase c-mediated calcium signaling","volume":"23","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2022.100003_bib53","doi-asserted-by":"crossref","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.labinv.2022.100003_bib54","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"10.1016\/j.labinv.2022.100003_bib55","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.3390\/ijms20184634","article-title":"FGF23-mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis","volume":"20","author":"B\u00f6ckmann","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2022.100003_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fendo.2018.00333","article-title":"Impact of altered mineral metabolism on pathological cardiac remodeling in elevated fibroblast growth factor 23","volume":"9","author":"Leifheit-Nestler","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.labinv.2022.100003_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.carpath.2019.02.001","article-title":"Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction","volume":"40","author":"Schumacher","year":"2019","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"10.1016\/j.labinv.2022.100003_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231905","article-title":"Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-\u03b21","volume":"15","author":"Kuga","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2022.100003_bib59","article-title":"Comprehensive expression analysis of cardiac fibroblast growth factor 23 in health and pressure-induced cardiac hypertrophy","volume":"9","author":"Eitner","year":"2021","journal-title":"Front Cell Develop Biol"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib60","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/j.labinv.2022.100003_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6363(00)00030-4","article-title":"Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis","volume":"46","author":"MacKenna","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.labinv.2022.100003_bib62","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-\u03b21","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.labinv.2022.100003_bib64","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/cells8080865","article-title":"Calcitriol attenuates doxorubicin-induced cardiac dysfunction and inhibits endothelial-to-mesenchymal transition in mice","volume":"8","author":"Tsai","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.labinv.2022.100003_bib65","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1172\/JCI67804","article-title":"A\u00a0nonclassical vitamin D receptor pathway suppresses renal fibrosis","volume":"123","author":"Ito","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ejcn.2017.59","article-title":"Effects of vitamin D or its analogues on the mortality of patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"10.1016\/j.labinv.2022.100003_bib67","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3390\/ijms22062896","article-title":"Vitamin D and cardiovascular disease: an updated narrative review","volume":"22","author":"Zittermann","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.labinv.2022.100003_bib68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.labinv.2022.100003_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:22:04Z","timestamp":1758396124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0023683722000034"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2022.100003","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2022.100003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100003"}}